The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Treatment of Parkinsonism with Levodopa: Follow-up After 2 Years of Treatment

[+] Article, Author, and Disclosure Information

▸Requests for reprints should be addressed to John E. Lee, M.D., 1300 York Ave., New York, N.Y. 10021

New York, New York

Ann Intern Med. 1971;75(5):703-708. doi:10.7326/0003-4819-75-5-703
Text Size: A A A

One hundred patients with Parkinson's disease began taking levodopa in 1968; 72 of them have continued treatment under close supervision for at least 2 years. After treatment for 2 years 82% of the patients were improved 25% or more compared with their pretreatment condition; 49% were improved 50% or more. Tremor improved more than did rigidity or akinesia. The average dose at 2 years was 4.5 g/day. Side effects were frequent but required treatment to be stopped in only three patients. Commonest were involuntary movements, nausea and transient delirium, and confusion and memory loss. The dementia associated with parkinsonism improved in some patients but progressed in others. Although parkinsonism did not appear to progress during levodopa treatment, a 2-year treatment experience does not permit us to draw conclusions as to the effect of levodopa on the natural history of Parkinson's disease. Levodopa continues to be the most effective treatment available.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
A case of Parkinson's disease following dystonia. Rinsho Shinkeigaku Published online Aug 6, 2016;
Advances in levodopa therapy for Parkinson disease. Neurology 2016;86(14 Suppl 1):S1-2.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.